Review article: New-onset diabetes after transplantation

Nephrology

Volumn 13, Issue 8, 2008, Pages 737-744

  Chow, Kai Ming ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Calcineurin inhibitor; Diabetes mellitus; Insulin resistance; New onset diabetes mellitus; Transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

DIABETES MELLITUS; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 58149138917     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01052.x     Document Type: Review

References (55)

1. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: A systematic review of the literature. Diabetes Care 2002 25 : 583 92.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 27 (Suppl 1 S5 10.
3. Markell M. New-onset diabetes mellitus in transplant patients: Pathogenesis, complications, and management. Am J Kidney Dis 2004 43 : 953 65.
4. Davidson J, Wilkinson A, Dantal J et al. International Expert Panel. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003 75 (Suppl 10 SS3 24.
5. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin. Transplant. 2005 19 : 291 8.
6. Bloom RD, Crutchlow MF. New-onset diabetes mellitus in the kidney recipient: Diagnosis and management strategies. Clin. J. Am. Soc. Nephrol. 2008 3 : S38 48.
7. Woodward RS, Schnitzler MA, Baty J et al. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am. J. Transplant. 2003 3 : 590 98.
8. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am. J. Transplant. 2003 3 : 178 85.
9. Arner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: A study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 1983 6 : 23 5.
10. Hur KY, Kim MS, Kim YS et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 2007 30 : 609 15.
11. Burroughs TE, Swindle J, Takemoto S et al. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation 2007 83 : 1027 34.
12. Turner R, Cull C, Holmon R. United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 1996 124 : 136 45.
13. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005 79 : 438 43.
14. Friedman EA, Shyh TP, Beyer MM, Manis T, Butt KM. Posttransplant diabetes in kidney transplant recipients. Am. J. Nephrol. 1985 5 : 196 202.
15. Boudreaux JP, McHugh L, Canafax DM et al. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 1987 44 : 376 81.
16. Miles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 1998 65 : 380 84.
17. Sumrani NB, Delaney V, Ding ZK et al. Diabetes mellitus after renal transplantation in the cyclosporine era - An analysis of risk factors. Transplantation 1991 51 : 343 7.
18. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin. Transplant. 2001 15 : 89 94.
19. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 2002 62 : 1440 46.
20. Gourishankar S, Jhangri GS, Tonelli M, Wales LH, Cockfield SM. Development of diabetes mellitus following kidney transplantation: A Canadian experience. Am. J. Transplant. 2004 4 : 1876 82.
21. González-Posada JM, Hernández D, Genis BB et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain. Clin. Transplant. 2006 20 : 650 58.
22. Chadban S. New-onset diabetes after transplantation - Should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients? Nephrol. Dial. Transplant. 2008 23 : 1816 18.
23. Matas AJ, Gillingham KJ, Humar A et al. Posttransplant diabetes mellitus and acute rejection: Impact on kidney transplant outcome. Transplantation 2008 85 : 338 43.
24. Cole EH, Johnston O, Rose CL, Gill JS. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin. J. Am. Soc. Nephrol. 2008 3 : 814 21.
25. Pham PT, Pham PC, Lipshutz GS, Wilkinson AH. New onset diabetes mellitus after solid organ transplantation. Endocrinol. Metab. Clin. North Am. 2007 36 : 873 90.
26. Jindal RM. Posttransplant diabetes mellitus - A review. Transplantation 1994 58 : 1289 98.
27. Crutchlow MF, Bloom RD. Transplant-associated hyperglycemia: A new look at an old problem. Clin. J. Am. Soc. Nephrol. 2007 2 : 343 55.
28. Midtvedt K, Hjelmesæth J, Hartmann A et al. Insulin resistance after renal transplantation: The effect of steroid dose reduction and withdrawal. J. Am. Soc. Nephrol. 2004 15 : 3233 9.
29. Gillison SL, Bartlett ST, Curry DL. Inhibition of cyclosporine of insulin secretion - A beta cell-specific alteration of islet tissue function. Transplantation 1991 52 : 890 95.
30. Nielsen JH, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic beta-cells. Diabetes 1986 35 : 1049 52.
31. Ricordi C, Zeng YJ, Alejandro R et al. In vivo effects of FK506 on human pancreatic islets. Transplantation 1991 52 : 519 22.
32. 2 Monitoring Versus Tacrolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 2007 7 : 1506 14.
33. Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ 2005 331 : 810
34. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am. J. Transplant. 2004 4 : 583 95.
35. Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP. Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction. J. Am. Soc. Neprhol. 2002 13 : 221 7.
36. Burroughs TE, Lentine KL, Takemoto SK et al. Influence of early posttransplantation prednisolone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin. J. Am. Soc. Nephrol. 2007 2 : 517 23.
37. Panz VR, Bonegio R, Raal FJ, Maher H, Hsu HC, Joffe BI. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation. Transplantation 2002 73 : 587 90.
38. Chow KM, Szeto CC, Li PK. Good metabolic control using tacrolimus-based immunosuppressants in primary cadaveric renal transplantation in Chinese - A preliminary report. Clin. Transplant. 2002 16 : 39 42.
39. Cheung CY, Wong KM, Chan HW et al. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. Transpl. Int. 2006 19 : 657 66.
40. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. New onset hyperglycemia in non-diabetic Chinese patients started on peritoneal dialysis. Am. J. Kidney Dis. 2007 49 : 524 32.
41. Li PK, Kwan BC, Szeto CC, Ko GT. Metabolic syndrome in peritoneal dialysis patients. Nephrol Dial Transplant Plus 2008 1 : 204 14.
42. Teutonico A, Schena PF, Di Paolo S. Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J. Am. Soc. Nephrol. 2005 16 : 3128 35.
43. Johnston O, Rose CL, Webster AC, Gill JS. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J. Am. Soc. Nephrol. 2008 19 : 1411 18.
44. Roland M, Gatault P, Doute C et al. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation. Transpl. Int. 2008 21 : 523 30.
45. Porrini E, Delgado P, Alvarex A et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol. Dial. Transplant. 2008 23 : 1436 41.
46. Chan HW, Cheung CY, Liu YL et al. Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: A single centre study. Nephrol Dial Transplant 2008 23 : 3337 42.
47. Araki M, Flechner SM, Ismail HR et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin inhibitors or mTOR inhibitor drugs. Transplantation 2006 81 : 335 41.
48. Bayés B, Granada ML, Pastor MC et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am. J. Transplant. 2007 7 : 416 22.
49. Chow KM, Szeto CC, Leung CB, Lui SF, Tong YF, Li PK. Body mass index as a predictive factor for long-term renal transplant outcomes in Asians. Clin. Transplant. 2006 20 : 582 9.
50. Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation 2008 85 : 353 8.
51. Delgado P, Diaz JM, Silva I et al. Unmasking glucose metabolism alterations in stable renal transplant recipients: A multicenter study. Clin. J. Am. Soc. Nephrol. 2008 3 : 808 13.
52. Kuypers DR, Claes K, Bammens B, Evenopoel P, Vanrenterghem Y. Early clinical assessment of glucose metabolism in renal allograft recipients: Diagnosis and prediction of post-transplant diabetes mellitus (PTDM). Nephrol. Dial. Transplant. 2008 23 : 2033 42.
53. Armstrong KA, Prins JB, Beller EM et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin. J. Am. Soc. Nephrol. 2006 1 : 100 108.
54. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007 84 : 285 91.
55. Shah T, Kasravi A, Huang et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 2006 82 : 1673 6.